Editorials |
From the Linus Pauling Institute, Oregon State University, Corvallis, Ore.
Correspondence to Balz Frei, Linus Pauling Institute, 571 Weniger Hall, Oregon State University, Corvallis, OR 97331. E-mail Balz.Frei@oregonstate.edu
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
In this issue of Arteriosclerosis, Thrombosis, and Vascular Biology, Keaney and colleagues1 report that smoking, diabetes, and obesity are independently associated with increased oxidative stress in men and women in a large community-based cohort. While a number of investigators have examined the association between risk factors for cardiovascular diseases (CVDs) and markers of oxidative stress in small clinical samples, Keaney and colleagues1 used the Framingham Offspring Cohort to assess CVD risk and urinary concentrations of the F2-isoprostane 8-epiPGF2
in more than 2800 men and women between 33 and 88 years of age. Although smoking and diabetes have been associated with increased oxidative stress in a number of studies, the finding that obesity, as measured by body mass index (BMI), is independently associated with oxidative stress is relatively new and confirms recent data from much smaller samples.2,3
See pages 368 and 434
F2-Isoprostanes are prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid. They are formed in situ esterified to phospholipids and are released into plasma by phospholipases.4 Plasma and urinary F2-isoprostanes are established biomarkers of lipid peroxidation in vivo.5 In humans, F2-isoprostanes are elevated in the presence of diabetes,6 hypercholesterolemia,7 end stage renal disease and hemodialysis,8 hyperhomocysteinemia,9 and cigarette smoking.2 Elevated concentrations of F2-isoprostanes have also been found in human atherosclerotic lesions.10 In addition to serving as biomarkers of oxidative stress, F2-isoprostanes, including 8-epiPGF2
, exert (patho)physiological effects such as vasoconstriction.11
Obesity is epidemic in the United States. Among adults, the age-adjusted
This article has been cited by other articles:
![]() |
S. Nambiar, S. Viswanathan, B. Zachariah, N. Hanumanthappa, and Sridhar Gopalakrishna Magadi Oxidative Stress in Prehypertension: Rationale for Antioxidant Clinical Trials Angiology, April 1, 2009; 60(2): 221 - 234. [Abstract] [PDF] |
||||
![]() |
A. Aviv, A. Valdes, J. P. Gardner, R. Swaminathan, M. Kimura, and T. D. Spector Menopause Modifies the Association of Leukocyte Telomere Length with Insulin Resistance and Inflammation J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 635 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Bernabucci, B. Ronchi, N. Lacetera, and A. Nardone Influence of Body Condition Score on Relationships Between Metabolic Status and Oxidative Stress in Periparturient Dairy Cows J Dairy Sci, June 1, 2005; 88(6): 2017 - 2026. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Gardner, S. Li, S. R. Srinivasan, W. Chen, M. Kimura, X. Lu, G. S. Berenson, and A. Aviv Rise in Insulin Resistance Is Associated With Escalated Telomere Attrition Circulation, May 3, 2005; 111(17): 2171 - 2177. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ghanim, A. Aljada, D. Hofmeyer, T. Syed, P. Mohanty, and P. Dandona Circulating Mononuclear Cells in the Obese Are in a Proinflammatory State Circulation, September 21, 2004; 110(12): 1564 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Esposito, F. Giugliano, C. Di Palo, G. Giugliano, R. Marfella, F. D'Andrea, M. D'Armiento, and D. Giugliano Effect of Lifestyle Changes on Erectile Dysfunction in Obese Men: A Randomized Controlled Trial JAMA, June 23, 2004; 291(24): 2978 - 2984. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |